BioSpace News Archive

BioCapital

Scientific Statement on Diagnosis and Treatment of Iron Deficiency in Heart Failure Released by Heart Failure Society of America

The Heart Failure Society of America (HFSA) today released a new scientific statement on iron deficiency in heart failure (HF).

May 1, 2023
·
3 min read
Business

Flatiron Health Embarks on Strategic Collaboration with Sanofi to Make Clinical Trials More Efficient by Streamlining Data Acquisition at the Point of Care

Flatiron Health announced a new collaboration today with Sanofi in their pursuit to redesign the clinical trial experience for sponsors, sites, and patients in the therapeutic area of oncology.

May 1, 2023
·
3 min read
Business

Find Therapeutics welcomes Dr. Jack Antel to its clinical advisory board

Find Therapeutics Inc., a biopharmaceutical company focused on the development of innovative therapies for autoimmune diseases, today announced the appointment of Dr. Jack Antel to its Clinical Advisory Board (CAB).

May 1, 2023
·
3 min read
Biotech Beach

ViaLase to Present Clinical Data at the 2023 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting

ViaLase, Inc. today announced that it will present first-in-human clinical data and a technology overview during the 2023 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting to be held May 5-8, 2023 in San Diego, California.

May 1, 2023
·
3 min read
AllyGPO Announces Addition of Mike Cunningham to its Board of Directors

AllyGPO, a next-generation, physician-led group purchasing organization (GPO) dedicated exclusively to community specialty practices, today announced the appointment of Mike Cunningham, PharmD, to its Board of Directors.

May 1, 2023
·
3 min read
Atmo Biosciences appoints world-renowned gastroenterologist Professor Eamonn Quigley as Medical Advisory Board Chair

U.S.-based Professor Quigley brings decades of experience in gastroenterological clinical practice and research as a key opinion leader at the highest levels.

May 1, 2023
·
3 min read
Biotech Beach

New Study Demonstrates The SaltFacial’s Non-Invasive Method for Enhancing Efficacy of Exosomes and Improving Skin Quality

A new study published in the Journal of Cosmetic Dermatology has shown that The SaltFacial, a non-invasive skin rejuvenation treatment, can enhance the efficacy of exosomes and improve skin quality through safe and effective methods.

May 1, 2023
·
2 min read
FDA

Guided Therapeutics Provides Update on Start of Clinical Trial for US FDA Approval

Guided Therapeutics, Inc. or the “Company” (OTCQB: GTHP), the maker of LuViva, a rapid and painless cervical cancer detection system based on the Company’s patented biophotonic technology, provided an update regarding the start of its pivotal clinical trial.

May 1, 2023
·
3 min read
Business

Lilly Declares Second-Quarter 2023 Dividend

The board of directors of Eli Lilly and Company has declared a dividend for the second quarter of 2023 of $1.13 per share on outstanding common stock.

May 1, 2023
·
2 min read
Drug Development

Travere Therapeutics Announces Topline Results from Two-Year Primary Efficacy Endpoint in Pivotal Phase 3 DUPLEX Study of Sparsentan in Focal Segmental Glomerulosclerosis

Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced topline primary efficacy results from the pivotal Phase 3 DUPLEX Study of sparsentan, a Dual Endothelin Angiotensin Receptor Antagonist (DEARA), in focal segmental glomerulosclerosis (FSGS).

May 1, 2023
·
19 min read